← Back to all trials
Not Yet Recruiting
NCT05724368
Efficacy of Calprotectin as A Marker For the Pathogenicity of Blastocystis Infection
Conditions: Blastocystis Infections
Sex: All
Ages: 6 Years – 70 Years
Healthy volunteers: 1
Enrollment: 150
Sponsor: Sohag University
Summary
Blastocystis which is commonly found in the gastro-intestinal tract, has been recognized as a non-pathogenic organism for a few decades.
It has a variable distribution.
A high prevalence has been reported in developing countries (22.1-100%).In developed countries, the prevalence ranges from 0.5% to 23.1%.
The high prevalence noted in developing countries is related to poor hygiene and lack of safe water and food .
Eligibility Criteria
Inclusion Criteria:Patients from outpatient clinics, Sohag hospitals.Exclusion Criteria:Patients taking antibiotics within the previous four weeks, and anti-parasitic drugs within the previous two weeks.
Source: ClinicalTrials.gov (NCT05724368). StuddyBuddy aggregates publicly available trial information.